Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Standardized reporting as a foundation for trustworthy and reproducible artificial intelligence in radiotherapy.

Physics and imaging in radiation oncology·2026

Same author

Maintaining quality of scientific peer-review and publishing in <i>Physics and Imaging in Radiation Oncology</i>.

Physics and imaging in radiation oncology·2026

Same author

What an RVU experiment taught me about Medical Physics.

Journal of applied clinical medical physics·2025

Same author

How Does the Precursor Influence the Li-Rich Layered Oxide Cathode?

Angewandte Chemie (International ed. in English)·2025

Same author

Beyond the bubble: reflections on a career in academic medicine with an obligation to look beyond.

Journal of applied clinical medical physics·2025

Same author

Financial Toxicity and Quality-of-Life Outcomes on a Phase 1 5-fraction Stereotactic Partial Breast Irradiation Protocol for Early-Stage Breast Cancer.

Practical radiation oncology·2024

Search research articles

Related Experiment Video

Updated: May 1, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Commissioning and initial stereotactic ablative radiotherapy experience with Vero.

Timothy D Solberg¹, Paul M Medin, Ezequiel Ramirez

¹University of Pennsylvania, University of Texas Southwestern Medical Center. timothy.solberg@uphs.upenn.edu.

Journal of Applied Clinical Medical Physics

|April 9, 2014

Summary

The Vero linear accelerator was commissioned for stereotactic ablative radiotherapy (SABR). Initial clinical performance shows it is suitable for advanced radiotherapy techniques and image-guided treatments.

More Related Videos

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Stereotactic Radiosurgery for Gynecologic Cancer

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Related Experiment Videos

Last Updated: May 1, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Stereotactic Radiosurgery for Gynecologic Cancer

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Area of Science:

Medical Physics
Radiation Oncology
Radiotherapy Technology

Background:

The Vero system is a novel radiotherapy device designed for image-guided stereotactic ablative radiotherapy (SABR).
Its ring gantry design allows for noncoplanar beam arrangements, crucial for precise SABR delivery.
The system integrates advanced imaging and beam delivery capabilities.

Purpose of the Study:

To detail the comprehensive commissioning process of the Vero linear accelerator.
To evaluate the initial clinical performance of the Vero system for SABR applications.
To validate the system's accuracy and reliability for advanced radiotherapy.

Main Methods:

Commissioning included beam data acquisition and dosimetric validation using Monte Carlo algorithms and credentialing phantoms.
Image-guided radiotherapy (IGRT) localization accuracy was evaluated through end-to-end testing.
System performance, including isocenter stability and clinical SABR applications, was assessed.

Main Results:

The commissioning process established the dosimetric accuracy and reliability of the Vero system.
Validation with specialized phantoms confirmed the system's performance for various treatment techniques.
Initial clinical experience demonstrated the Vero system's capability for precise SABR delivery.

Conclusions:

The Vero linear accelerator is a capable platform for image-guided SABR, supporting diverse treatment modalities.
The comprehensive commissioning and validation process confirm its suitability for clinical use.
The system's performance indicates its potential to enhance radiotherapy precision and patient outcomes.